Sir David William Cross MacMillan FRS FRSE (born 16 March 1968)[2] is a Scottish[8] chemist and the James S. McDonnell Distinguished University Professor of Chemistry at Princeton University, where he was also the chair of the Department of Chemistry from 2010 to 2015.[9][10] He shared the 2021 Nobel Prize in Chemistry with Benjamin List "for the development of asymmetric organocatalysis".[11] MacMillan used his share of the $1.14 million prize to establish the May and Billy MacMillan Foundation.[12]
Sir David MacMillan | |
|---|---|
 MacMillan in 2021 | |
| Born | David William Cross MacMillan 16 March 1968 |
| Citizenship | United Kingdom United States[1] |
| Education | Bellshill Academy |
| Alma mater | University of Glasgow (BSc) University of California, Irvine (MSc, PhD) |
| Awards | Corday-Morgan medal Member of the National Academy of Sciences (2018) Nobel Prize in Chemistry (2021) |
| Scientific career | |
| Institutions | |
| Thesis | Stereocontrolled formation of bicyclic tetrahydrofurans and Enantioselective total synthesis of eunicellin diterpenes (1996) |
| Doctoral advisor | Larry E. Overman |
| Other academic advisors | Ernest W. Colvin David A. Evans |
| Doctoral students | Vy Dong, Tehshik Yoon |
| Website | Official website |
Education and early life
MacMillan was born in Bellshill, North Lanarkshire, Scotland, in 1968 and grew up in nearby New Stevenston.[13] He attended the local state-funded schools, New Stevenston Primary and Bellshill Academy, and credited his Scottish education and Scottish upbringing for his success.[14][13]
He received his undergraduate degree in chemistry at the University of Glasgow, where he worked with Ernie Colvin.[15][16]
In 1990, he left the UK to begin his doctoral studies under the direction of Professor Larry Overman at the University of California, Irvine. During this time, he focused on the development of new reaction methodology directed toward the stereocontrolled formation of bicyclic tetrahydrofurans. MacMillan's graduate studies culminated in the total synthesis of 7-(−)-deacetoxyalcyonin acetate, a eunicellin diterpenoid isolated from the soft coral Eunicella stricta.[17] He earned his Ph.D. in 1996.[16]
Career and research
Upon receiving his Ph.D., MacMillan accepted a postdoctoral position with Professor David Evans at Harvard University. His postdoctoral studies centered on enantioselective catalysis, in particular, the design and development of Sn(II)-derived bisoxazoline complexes (Sn(II)box).[16]
MacMillan began his independent research career as a member of the chemistry faculty at the University of California, Berkeley in July 1998. He joined the department of chemistry at Caltech in June 2000, where his group's research interests centered on new approaches to enantioselective catalysis. In 2004, he was appointed as the Earle C. Anthony Professor of Chemistry. He became the James S. McDonnell Distinguished University Professor at Princeton University in September 2006.[16]
He is considered to be one of the founders of organocatalysis.[18] In 2000, MacMillan designed small organic molecules that can provide or accept electrons and therefore efficiently catalyse reactions.[18][19] He developed catalysts that can drive asymmetric catalysis, in which a reaction produces more of the left-handed version of a molecule than the right-handed one (chirality), or vice versa.[18] MacMillan's research group has made many advances in the field of asymmetric organocatalysis, and they have applied these new methods to the synthesis of a range of complex natural products.[16][18] He developed chiral imidazolidinone catalysts.[20][19][21] MacMillan catalysts are used in various asymmetric syntheses. Examples include Diels-Alder reactions,[19] 1,3-dipolar cycloadditions,[22] Friedel-Crafts alkylations[23] or Michael additions.[21]
MacMillan has also extensively developed photoredox catalysis for use in organic synthesis.[24][25][26]
Between 2010 and 2014, MacMillan was the founding editor-in-chief of the journal Chemical Science, the flagship general chemistry journal published by the Royal Society of Chemistry.[16]
As of March 2024[update], MacMillan has an h-index of 125 according to Google Scholar[27] and of 115 according to Scopus.[28]
Visit to Brasil
In April 2024, David MacMillan was in Brazil for events at the State University of Rio de Janeiro and the University of São Paulo.[29] In Rio, MacMillan asked to visit the headquarters of General Severiano, from Botafogo, and was received by the Club's board of directors.[30] Later in São Paulo, MacMillan held a short panel at University of São Paulo Chemistry Institute (IQ-USP) about his history as a researcher and recent Nobel laureate.
Honours and awards
MacMillan was knighted in the 2022 Birthday Honours for services to chemistry and science.[31][32]
- 2002 – Sloan Research Fellowship[33]
- 2004 – Corday-Morgan medal of Royal Institute of Chemistry[34]
- 2012 – Elected a Fellow of the Royal Society (FRS)[35][36]
- 2012 – Elected as a member of the American Academy of Arts and Sciences[37]
- 2013 – Elected a Corresponding Fellow of the Royal Society of Edinburgh (FRSE)[38]
- 2015 – Harrison Howe Award[39]
- 2017 – Ryoji Noyori Prize[40]
- 2018 – Elected a member of the National Academy of Sciences[16]
- 2021 – Nobel Prize in Chemistry[11]
List
References
External links
- David MacMillan on Nobelprize.org
